A small change to a powerful molecular tool — using the CRISPR-Cas13 enzyme, which can detect RNA from viruses and cells — ...
Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment ...
The Fiesta Bowl matchup between No. 6 Mississippi and No. 10 Miami turned into an instant classic, with the Hurricanes coming from behind to win 31-27 and advance to the College Football Playoff ...
The NFL has an ongoing officiating crisis, one that it will never publicly admit. The problem becomes most conspicuous as to the issue of pass interference. In both Week 16 and Week 17, key late ...
Research into how a father’s choices — such as diet, exercise, stress, nicotine use — may transfer traits to his children has become impossible to ignore. The standard sperm-meets-egg story posits ...
With six drugs approved for commercial development, Cambridge-based drugmaker Alnylam Pharmaceuticals Inc. is investing $250 million into its biomanufacturing plant in Norton. The expansion comes as ...
New platform is expected to substantially increase manufacturing capacity and lower production costs, enabling investment in expanding pipeline FDA has accepted Alnylam’s enzymatic ligation ...
It was 2012 when Love Dalén, a paleogeneticist at Stockholm University, first laid eyes upon a special specimen on a lab table in eastern Siberia. "Our Russian collaborators said, 'Come here into this ...
Eli Lilly has penned a research pact worth $1.2 billion in biobucks with SanegeneBio to help pinpoint cardiometabolic RNAi medicines at the correct tissues. The agreement centers around Sanegene’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results